Affiliations 

  • 1 Department of Chemical and Process Engineering, Faculty of Engineering and Built Environment, Universiti Kebangsaan Malaysia, 43600 UKM Bangi, Selangor, Malaysia E-mail: yh_teow@ukm.edu.my; Research Centre for Sustainable Process Technology, Faculty of Engineering and Built Environment, Universiti Kebangsaan Malaysia, 43600 UKM Bangi, Selangor, Malaysia
  • 2 Department of Civil Engineering, Politeknik Sultan Idris, Sungai Lang 45100, Sungai Air Tawar, Selangor, Malaysia
  • 3 Department of Chemical and Process Engineering, Faculty of Engineering and Built Environment, Universiti Kebangsaan Malaysia, 43600 UKM Bangi, Selangor, Malaysia E-mail: yh_teow@ukm.edu.my; Ralph E Martin Department of Chemical Engineering, University of Arkansas, Fayetteville, AR 72701, USA
Water Sci Technol, 2023 Mar;87(5):1056-1071.
PMID: 36919733 DOI: 10.2166/wst.2023.034

Abstract

This research aims to evaluate the performance of PolyCera® Titan membrane for different wastewater treatment. Membrane filtration of several cycles was conducted in understanding the fouling mechanism, fouling propensity, and defouling potential of the PolyCera® Titan which had not been studied by any other researcher before. The PolyCera® Titan membrane is effective for the treatment of textile industry wastewater, palm oil mill effluent (POME), leachate, and semiconductor-industry wastewater. Rejection of methylene blue (MB) and Congo red (CR) was in the range of 78.76-86.04% and 88.89-93.71%, respectively; 94.72-96.50% NaCl, 96.07-97.62% kaolin, and 97.26-97.73% glucose were rejected from synthetic leachate indicating the removal of TDS, TSS, and COD from the leachate, respectively. Standard blocking and complete model were the best models used to explain the PolyCera® Titan membrane fouling mechanism in all types of wastewater treatment processes with a high R2 value. Physical cleaning with the use of distilled water was able to recover the permeate flux with the flux recovery ratio (FRR) value in the range of 79.2-95.22% in the first cycle, 81.20-98.16% in the second cycle, and 86.09-95.96% in the third cycle.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.